Regulatory Roundup: FDA and Georgetown University Form Innovation Partnership - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Regulatory Roundup: FDA and Georgetown University Form Innovation Partnership

ePT--the Electronic Newsletter of Pharmaceutical Technology

FDA and Georgetown University Medical Center have entered a partnership to stimulate innovation in regulatory science, ethics, education, and training, according to a Feb. 24, 2011, agency press announcement. Joint activities will include: research and public-health activities in areas such as novel technologies, public health preparedness, ethics, and bioinformatics; mentorship of doctoral and postdoctoral students in collaborative research relevant to FDA’s mission; scientific staff exchanges and professional-development opportunities, including selected FDA staff serving as adjunct faculty in teaching and clinical activities at Georgetown and selected Georgetown staff participating in research and other activities with FDA; and shared access to and development of important training and continuing education activities.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
26%
Oversee medical treatment of patients in the US.
12%
Provide treatment for patients globally.
10%
All of the above.
43%
No government involvement in patient treatment or drug development.
10%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Source: ePT--the Electronic Newsletter of Pharmaceutical Technology,
Click here